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120-catenin stabilizes epithelial cadherin (E-cadherin)
in SW48 cells, but the mechanism has not been estab-
lished. Here, we show that p120 acts at the cell surface
to control cadherin turnover, thereby regulating cadherin
levels. p120 knockdown by siRNA expression resulted
in dose-dependent elimination of epithelial, placental,
neuronal, and vascular endothelial cadherins, and complete
p
 
loss of cell–cell adhesion. ARVCF and 
 
 
 
-catenin were
functionally redundant, suggesting that proper cadherin-
dependent adhesion requires the presence of at least
one p120 family member. The data reveal a core function
of p120 in cadherin complexes, and strongly predict a
dose-dependent loss of E-cadherin in tumors that partially
or completely down-regulate p120.
 
Introduction
 
p120-catenin (p120) is the prototypic and most abundant
member of an Arm-domain protein subfamily that includes
ARVCF, 
 
 
 
-catenin, and p0071 (for review see Anastasiadis
and Reynolds, 2000). p120 was originally described as a
substrate for Src- and receptor tyrosine kinases (Reynolds et
al., 1989, 1992), and later was identified as a catenin
(Reynolds et al., 1994; Shibamoto et al., 1995), one of several
cofactors that interact with the cadherin tail and modulate
cadherin function (for review see Anastasiadis and Reynolds,
2000). The classical catenins, 
 
 
 
- and 
 
 
 
-catenin, bridge
the cadherin cytoplasmic domain to the underlying actin
cytoskeleton. p120 is required to stabilize epithelial cadherin
(E-cadherin) in SW48 cells (Ireton et al., 2002), and may also
regulate cadherin–cytoskeletal connections indirectly through
functional interactions with Rho GTPases (Anastasiadis et
al., 2000; Noren et al., 2000; Grosheva et al., 2001; Magie
et al., 2002; for review see Anastasiadis and Reynolds, 2001),
but the underlying mechanisms have not been established.
E-cadherin is the main cell–cell adhesion molecule in
epithelial tissues and is regarded as a master organizer of the
epithelial phenotype (Takeichi, 1995). Direct mutation of
the E-cadherin gene in gastric and lobular breast carcinomas
indicates a classical tumor suppressor role in some tumors
(Oda et al., 1994; Berx et al., 1995). In late-stage carcinomas
of all types, E-cadherin down-regulation occurs frequently
via epigenetic mechanisms (Comijn et al., 2001; Matsumura
et al., 2001) and is closely correlated with the transition to
metastasis (Frixen et al., 1991; Vleminckx et al., 1991;
Birchmeier and Behrens, 1994; Perl et al., 1998). Together,
these data establish E-cadherin as a tumor and/or metastasis
suppressor, depending on the mechanism and timing of
E-cadherin down-regulation (for review see Yap, 1998;
Nollet et al., 1999).
In the event of E-cadherin down-regulation, 
 
 
 
- and
 
 
 
-catenins are rapidly degraded (Nagafuchi et al., 1991) via
an adenomatous polyposis coli–dependent mechanism (Po-
lakis, 2000) that ultimately targets 
 
 
 
-catenin for destruction by
the proteosome (for review see Kikuchi, 2000). In contrast,
p120 is stable in the absence of cadherins and becomes
stranded in the cytoplasm (Thoreson et al., 2000). Ourselves
and others have postulated that cytoplasmic p120 actively
drives the metastatic phenotype in cadherin-deficient cells
through inappropriate activation/suppression of various
Rho-GTPases such as Rac1 and RhoA (Anastasiadis et al.,
2000; Noren et al., 2000; Anastasiadis and Reynolds, 2001;
Grosheva et al., 2001). These data suggest a metastasis
promoter role for p120 when mislocalized through prior
loss of E-cadherin.
Down-regulation of p120 occurs frequently in colon,
prostate, breast, lung, and other carcinoma types (for review
see Thoreson and Reynolds, 2002), but the consequences are
unknown. Paradoxically, it is rare to see p120 down-regulation
in established tumor cell lines. The lone exception is the
SW48 colon carcinoma cell line, where genetic alterations
result in extremely low levels of a mutated p120 that lacks
the carboxy terminus (Ireton et al., 2002). Restoring normal
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levels of full-length p120 expression in these poorly orga-
nized cells stabilized E-cadherin and caused a striking rescue
of epithelial morphology. Thus, in SW48 cells at least, p120
appears to be essential for E-cadherin stability and function
(Ireton et al., 2002). On the other hand, recent reports in
 
Drosophila
 
 (Myster et al., 2003; Pacquelet et al., 2003) and
 
Caenorhabditis elegans
 
 (Pettitt et al., 2003) indicate that
p120 is not essential, and that its absence causes only minor
defects that are not fully apparent unless complemented by
weak alleles of E-cadherin or 
 
 
 
-catenin.
Here, to clarify the role of p120 in mammalian cells, we
have knocked down p120 with siRNA in cells expressing ep-
ithelial (E-), placental (P-), neuronal (N-), and vascular en-
dothelial (VE-) cadherins. We report that each of these cad-
herins, as well as 
 
 
 
- and 
 
 
 
-catenins, were rapidly degraded
in the absence of p120, resulting in loss of cell–cell adhesion.
The effect was clearly dose dependent, indicating that p120
expression levels may directly determine cadherin levels.
Degradation of p120-uncoupled cadherin occurred after its
arrival at the surface, indicating that p120 regulates cadherin
turnover at the level of internalization or recycling. p120 ho-
mologues ARVCF and 
 
 
 
-catenin could substitute for p120,
so at least one family member is likely required to maintain
adhesion. Thus, cadherin complexes are rapidly turned over
and degraded in mammalian cells in the absence of direct in-
teraction with p120 or a p120 family member. These obser-
vations establish a core function for p120 in the cadherin
complex and have additional implications in support of a
role for p120 in tumor suppression.
 
Results
 
p120 loss leads to loss of the cadherin complex
 
To directly address the general consequences of p120 defi-
ciency, we stably expressed p120-specific siRNA using the
pRetroSuper (pRS) retrovirus to knockdown p120 in mam-
malian cell lines (Fig. 1). Human and murine p120 siRNAs
(h siRNA and m siRNA, respectively) were generated
against homologous human and murine sequences that dif-
fer by three mismatches at the nucleotide level (Fig. 1 a). Pi-
Figure 1. p120 knockdown eliminates the E-cadherin complex and abolishes adhesion. (a) Human and murine p120 siRNAs (h siRNA and 
m siRNA, respectively) were generated against homologous human and murine sequences that contain three mismatches at the nucleotide 
level (asterisks). (b) Schematic depicting a novel method for in vitro p120 knock-down and knock-up. Human p120 was knocked down using 
the retroviral vector pRS to express human-specific p120 siRNA, and stable cell lines were selected. p120 was then reexpressed (knock-up) 
by infecting the knock-down cell line with an LZRS retrovirus containing murine p120 cDNA. (c) Wild-type A431 cells (lane 1) were infected 
with virus carrying the control m siRNA (lane 2) or h siRNA (lane 3), and stable cell lines were isolated. p120 expression was restored (knock-up) 
by infecting h siRNA–expressing cells with retrovirus containing murine p120 (lane 4). The indicated cadherin complex proteins were analyzed 
by Western blotting whole cell lysates. E-cadherin,  -catenin, and  -catenin levels were substantially reduced in p120 knockdown cells, and 
restoring p120 reversed the effect. (d) p120 (i and vii), E-cadherin (ii and viii),  -catenin (iii and ix),  -catenin (iv and x), tubulin (v and xi), 
and vinculin (vi and xii) were localized by immunofluorescence in stable A431 cell lines expressing the control m siRNA (i–vi) or h siRNA 
(vii–xii). Cells were plated sparsely to allow colonies to emerge from single cells. Note that p120 knockdown cells lack cadherin complexes 
and have lost cell–cell adhesion. The cadherin complex is selectively targeted because the levels of tubulin and vinculin are unaffected.T
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lot experiments revealed that the h siRNA strongly knocked
down p120 levels in human cells, but not murine cells, and
vice versa. E-cadherin levels were also severely reduced by
p120 knockdown in several different epithelial cell lines.
These data indicate that the stabilizing effect of p120 is not
limited to SW48 cells, but represents a mechanism that is
likely common to all E-cadherin–expressing cells.
By intentionally targeting the above siRNA oligos to human
and murine sequences that differed by several nucleotides, it
was relatively straightforward to efficiently “knock down”
p120 with the human-directed siRNA (pRS-h siRNA) and
subsequently “knock up” p120 by infection with pLZRS-
mp120, a retrovirus containing the murine p120 cDNA (Fig.
1 b). Restoring p120 levels by expressing murine p120 reversed
the effects of the h siRNA and restored adhesion (Fig. 1, b and
c). It is worth noting that this method is generally applicable to
any protein. If a homologous gene is not available, a knock-up
construct can be generated by making silent mutations in the
region targeted by the siRNA. The method is a simple in vitro
equivalent of transgenic knock-out and knock-in technology,
and essentially solves the common dilemma associated with ex-
pressing mutant proteins in cells that already contain high lev-
els of an endogenous counterpart. To our knowledge, this is
the first example of this broadly applicable method.
To examine the effects of p120 knockdown in detail, we
isolated stable clones of A431 cells expressing p120-specific
siRNA and characterized them by Western blotting (Fig. 1 c)
and by immunofluorescence (Fig. 1 d). p120 was nearly elim-
inated by h siRNA (Fig. 1 c, lane 3), but not by m siRNA
(Fig. 1 C, lane 2), and p120 loss induced near complete loss of
E-cadherin. Levels of 
 
 
 
- and 
 
 
 
-catenin were also severely re-
duced, as expected from the fact that these catenins are stabi-
lized via interaction with cadherins. Thus, p120 loss essen-
tially eliminated the entire cadherin complex. Levels of
vinculin, which concentrate at focal adhesions in these cells,
were unaffected, as were levels of tubulin.
Figure 2. The p120-associated destruction 
mechanism is common to multiple cadherins. 
A431 (human cervical carcinoma), HUAEC, and 
C2C12 (mouse myocyte) cells express E- and
P-cadherin, VE-cadherin, and N-cadherin, respectively. 
Each cell line was infected with either human- or 
murine-specific p120 siRNA retrovirus to generate 
polyclonal knockdown cell lines, and levels of 
p120 or E-, P-, VE-, and N-cadherins were assayed 
by Western blotting of whole-cell lysates. Tubulin 
levels were used as a loading control. p120 knock-
down reduced expression of all these cadherins, 
indicating that its function is common to most 
(if not all) p120-associated cadherins. Note that the 
effects of the h and m siRNAs used for knockdown 
and control in the human cell lines are reversed in 
the murine cell line C2C12.
Figure 3. p120 levels act as a set point 
mechanism for determining cadherin 
levels. (a) Assay of relationship between 
p120 and E-cadherin levels by immuno-
fluorescent staining. A431 cells express-
ing p120 siRNA were infected with the 
murine p120 retrovirus and plated 
sparsely so that individual clones could 
emerge that expressed widely varying 
amounts of murine p120. Cells were co-
stained by immunofluorescence to ex-
amine the p120–E-cadherin relationship 
and its affect on cell–cell adhesion. 
p120 loss (i) caused complete loss of 
E-cadherin (ii) and the cells were 
nonadhesive. Intermediate levels of p120 
expression (panel iii) permitted intermedi-
ate levels of E-cadherin (panel iv), and 
cell–cell adhesion was partially restored. 
Higher than normal levels of p120 
(panel v) strongly induced E-cadherin (vi) 
and cell–cell adhesion was robust. These 
experiments reveal a direct relationship 
between p120 and E-cadherin levels, and the extent of cell–cell adhesion is directly affected. (b) Quantitative assessment of relationship 
between p120 and E-cadherin levels. A polyclonal population of cells expressing p120 siRNA was generated by retroviral infection. Individual 
clones within the population express different levels of p120 depending on integration events that affect the efficiency of the siRNA expression. 
Using E-cadherin antibodies (HECD-1), the cells were separated by FACS
® into pools expressing progressively lower levels of E-cadherin. Cell 
lysates from the samples were split and then Western blotted with anti-p120 (mAb pp120) or anti-E-cadherin (C-20820).T
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Analysis of the p120 knockdown cells by immunofluores-
cence revealed near complete loss of junctional E-cadherin,
loss of 
 
 
 
- and 
 
 
 
-catenins, and loss of cell–cell adhesion (Fig.
1 d). It is noteworthy that other adhesion systems (e.g., des-
mosomes) cannot compensate for loss of the core compo-
nents of the adherens junction. These observations reveal
that p120 is essential for adhesion and suggest a core func-
tion for p120 in regulating cadherin turnover.
 
The requirement for p120 is common to other cadherins
 
To determine whether the consequence of p120 knockdown
pertains only to E-cadherin, we repeated the experiments de-
scribed in Fig. 1 on cells expressing E-, P-, VE-, and N-cad-
herins (Fig. 2). A431 (human cervical carcinoma), human
umbilical aortic vascular endothelial (HUAEC), and C2C12
(murine myoblast) cells were selected because they express E-
and P-cadherin, VE-cadherin, and N-cadherin, respectively.
Interestingly, the levels of each of these cadherins were sub-
stantially reduced by p120 knockdown (Fig. 2, lanes 3, 6, and
9). Note that because C2C12 cells are murine, the constructs
are reversed relative to the human lines; m siRNA is the
knockdown construct and the h siRNA is the control. The
knockdown levels in these experiments are not quite as strik-
ing as in the clonal cell lines represented in Fig. 1 because they
are polyclonal cell lines, and therefore represent the average
siRNA expression and knockdown from multiple integration
events. Nonetheless, these data indicate clearly that the mech-
anism of stabilization by p120 is common to a wide variety of
cadherins, probably all cadherins that bind p120.
 
p120 levels directly determine cadherin levels
 
To more accurately quantify the relationship between p120
and cadherin expression, we infected A431 cells with the p120
siRNA virus and analyzed individual cell clones by coimmu-
nofluorescence for p120 and E-cadherin (unpublished data).
We also performed the reverse experiment (knock-up) by in-
troducing murine p120 into the h siRNA-expressing A431
cells (Fig. 3). In all cases, there was a striking correlation be-
tween the levels of p120 and E-cadherin, which was also re-
flected by the extent of cell–cell adhesion. In the absence of
p120, there was essentially no E-cadherin present (Fig. 3, i
and ii). By contrast, intermediate levels of p120 caused inter-
mediate levels of E-cadherin and partial restoration of epithe-
lial morphology (Fig. 3, iii and iv). When murine p120 was
expressed at higher than normal levels, E-cadherin levels were
correspondingly elevated and exceeded the wild-type levels
observed in the parental cell lines (Fig. 3, v and vi; see also Fig.
1 c). Panels v and vi are overexposed because the common ex-
posure time for the entire panel was chosen to allow better vi-
sualization of the low and intermediate p120 levels.
We also quantified the relationship between p120 and
E-cadherin expression by FACS
 
®
 
 analysis of a population of
p120 siRNA-infected cells with mAb-HECD1, which rec-
ognizes the extracellular domain of human E-cadherin (Fig.
3 b). The cells were sorted into pools with progressively de-
creasing levels of surface E-cadherin. Cell lysates were gen-
erated from each pool, divided in half, and then Western
blotted for E-cadherin and p120 (Fig. 3 b). As in the immu-
nofluorescent assays, the levels of p120 closely paralleled the
levels of E-cadherin.
Together, these data show that E-cadherin levels faithfully
reflect the level of p120 expression in individual cells, and
show that the levels of E-cadherin can be experimentally ti-
trated by increasing or decreasing the levels of p120.
 
p120 family members can functionally substitute 
for p120
 
In most epithelial cell lines, p120 is abundant and its close
relatives such as ARVCF and 
 
 
 
-catenin are poorly expressed
or absent. Although p120 knockdown was sufficient to
nearly eliminate E-cadherin in several epithelial cell lines
tested, the effect was incomplete in cells such as the colon
carcinoma cell line HCT116. An obvious explanation is that
p120 family members might partially or completely substi-
tute for p120, depending on their relative abundance. In-
deed, HCT116 cells are unusual in that they express moder-
ate levels of ARVCF (unpublished data). To determine
whether other p120 relatives can also regulate E-cadherin
Figure 4. Redundant roles for p120 family members ARVCF and 
 -catenin. A431 cells stably expressing human p120 siRNA were 
transiently transfected with ARVCF-GFP,  -catenin–GFP, or myc-
tagged plakophilin-3 (Pkp-3-myc). 24 h after transfection, cells were 
plated sparsely and individual colonies grew for 2 d. Levels of the 
transfected proteins and E-cadherin were then analyzed by immuno-
fluorescence. GFP expression alone (i, eluminated cells) did not 
affect E-cadherin levels (ii). Both ARVCF-GFP (iii) and  -catenin–GFP 
(v) substantially increased levels of E-cadherin (iv and vi) and rescued 
cell–cell adhesion. In contrast, plakophilin-3 (vii), a p120-related 
protein that does not bind classical cadherins, but had no effect on 
E-cadherin levels (viii) or cell–cell adhesion.T
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turnover, we transiently expressed GFP-labeled ARCVF or
 
 
 
-catenin in A431 cells that lack p120 as a result of siRNA
knockdown (Fig. 4). As a negative control, we also tested
plakophilin-3, a more distant p120 relative that binds des-
mosomal (but not classical) cadherins. A431 cells expressing
p120 siRNA alone were almost completely E-cadherin nega-
tive (Fig. 4, i and ii), as described earlier in this paper, and
were not affected by GFP expression (Fig. 4 i, fluorescent
cells). ARVCF (Fig. 4, iii) and 
 
 
 
-catenin (Fig. 4, v) localized
to adherens junctions and efficiently rescued adhesion by re-
storing normal E-cadherin levels (Fig. 4, iv and vi). In con-
trast, myc-tagged plakophilin-3 (Fig. 4 vii, stained cells) did
not affect cadherin levels (Fig. 4 viii) and failed to restore
cell–cell contacts. Thus, there is a clear redundant role
among close family members with regard to cadherin stabili-
zation, and the occasional significant presence of a p120
family member (e.g., ARVCF in colon HCT116 cells) is
likely to account for the fact that E-cadherin loss does not
perfectly parallel p120 loss in some cell lines.
 
Mechanism of E-cadherin loss
 
p120 reportedly is the first of the catenins to bind newly
synthesized N-cadherin, and coprecipitates with the nascent
precursor form of N-cadherin (Wahl et al., 2003). Because
of the extraordinary efficiency of E-cadherin destruction af-
ter p120 knockdown, we first considered the possibility that
p120 binding was necessary to stabilize E-cadherin during or
after protein translation and before arrival at the cell surface.
Figure 5. p120 regulates E-cadherin turnover at the cell membrane. (a) E-cadherin synthesis and processing in p120 knockdown cells. 
E-cadherin turnover was examined by pulse-chase analysis of parental and h p120 siRNA-expressing A431 cells.  - and  -Catenin processing 
from the same experiment are shown below. Chase times are indicated across the top. At chase time 0 (15 min after initiation of the pulse 
labeling), E-cadherin synthesis was identical in the presence and absence of p120 (a, compare E-cadherin bands). The processing of the pro- 
(pro-E-cad) and mature (E-cad.) forms were identical for at least 1 h. Soon thereafter, E-cadherin degradation was significantly accelerated in 
the absence of p120. (b) Analysis of total E-cadherin surface levels in parental and p120 knockdown A431 cells. The parental and p120 
knockdown A431 cells were biotinylated for 20 min at 4 C to label surface cadherins. To specifically measure the surface levels, E-cadherin 
was first immunoprecipitated directly with E-cadherin mAb HECD-1. The sample was eluted with 0.5% SDS and then reprecipitated with 
streptavidin-coated beads to isolate the surface-labeled pool. E-cadherin levels at the surface in p120 knockdown cells (lane 1) are at least 
100-fold diminished relative to the parental cells (lane 2). The result in lane 2 shows that the surface E-cadherin can be efficiently labeled 
(and detected) by this method. (c) Tracking the arrival of newly synthesized E-cadherin to the cell surface. The methods in a and b were 
combined to determine whether newly synthesized E-cadherin could transit to the cell surface in the absence of p120. The results in c were 
quantified by densitometry and represented graphically in d. Parental and p120 knockdown (h siRNA) cells were labeled with [
35S]methionine 
for 15 min, chased at 37 C for the times indicated across top, and placed on ice (4 C) to suspend trafficking. Cell surface proteins were 
immediately biotinylated at 4 C for 20 min as in b. Surface E-cadherin was then isolated as in b, and the nascent [
35S]methionine E-cadherin 
pool was visualized by SDS-PAGE and radiography. Nascent E-cadherin appeared at the surface at 30 min and peaked at 1 h. The absence of 
p120 had no effect on this result. Therefore, p120 is not required for E-cadherin synthesis or trafficking, but is essential to regulate E-cadherin 
turnover soon after its arrival at the cell surface.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
530 The Journal of Cell Biology 
 
|
 
 
 
Volume 163, Number 3, 2003
 
To examine E-cadherin synthesis in the absence of p120, we
labeled the p120 knockdown A431 cells with [
 
35
 
S]methio-
nine and performed pulse-chase experiments (Fig. 5 a). In-
terestingly, the rate of E-cadherin synthesis was unaffected
by the absence of p120 (Fig. 5 a, compare top panels).
Moreover, the processing and turnover of both the precursor
and mature forms of E-cadherin were identical for at least 1
h after the pulse, after which the cadherin degradation
curves diverged rapidly. Degradation of 
 
 
 
- and 
 
 
 
-catenins
paralleled the loss of E-cadherin, as expected from the fact
that these catenins are stabilized by cadherin binding.
The fact that the newly synthesized cadherin behaved
identically in the presence and absence of p120 for 1 h, and
until after the precursor form disappeared, suggests that cad-
herin degradation occurred after arrival at the cell surface.
The result was initially surprising because examination of to-
tal surface levels of E-cadherin in the p120 knockdown cells
(h siRNA) and parental cell lines (Fig. 5 b) showed that al-
though surface E-cadherin could be efficiently isolated by bi-
otin labeling and streptavidin pulldown (e.g., Fig. 5 b, lane
2), it was 
 
 
 
100-fold less abundant in the p120-deficient
cells (Fig. 5 b, compare lane 1 with lane 2).
To definitively address this issue, we combined the pulse-
chase and biotin surface-labeling strategies in order to selec-
tively examine the fate of the nascent E-cadherin molecules
with respect to their arrival at the cell surface (Fig. 5 c). The
pulse labeling was conducted as in Fig. 5 a, except that sur-
face E-cadherin was subsequently biotin labeled (as in Fig. 5
b) at each time point after the pulse chase. The surface-
labeled cadherins were then isolated by streptavidin pull-
down, and nascent cadherins were visualized by SDS-PAGE
and autoradiography. The data show that the rate of nascent
E-cadherin arrival at the cell surface is almost identical in the
presence and absence of p120 (Fig. 5, c and d; compare pa-
rental and siRNA cell lines). The appearance and removal of
E-cadherin from the cell surface (Fig. 5 c; E-cadherin 
 
 
 
streptavidin immunoprecipitations) are quantified by densi-
tometry and displayed graphically in Fig. 5 d. Note that
peak levels of nascent (
 
35
 
S-labeled) E-cadherin at the cell sur-
face occurred at 1 h, and by 4 h, the nascent cadherin was ei-
ther moving off the surface or getting degraded. The timing
is consistent with the 4-h time point in Fig. 5 a, which
marks the first interval where degradation of the unbound
cadherin sharply accelerates. Clearly, E-cadherin transits
normally to the surface in the absence of p120, but is then
rapidly turned over.
To identify the mechanism of degradation, we treated
p120 knockdown cells with over 30 agents known to inhibit
factors that have been reported to affect cadherin stability
and turnover. Examples include inhibitors of presenilin-1,
caspases, metalloproteinases, and calpain. Cells were incu-
bated for 24 h with predetermined amounts of the various
inhibitors, and then analyzed by immunofluorescence (un-
published data) or Western blotting for changes in levels of
E-cadherin (Fig. 6). Although the majority of the inhibitors
had no affect, several proteosome inhibitors (i.e., PS341, lac-
tacystin, and MG132) significantly blocked E-cadherin deg-
radation (Fig. 6; lactacystin, lanes 1 and 2; PS341, lanes 3
and 4). The reduced amount of E-cadherin at the higher
PS341 dose (Fig. 6, compare lane 3 with lane 4) reflects tox-
icity of this compound. Of the two commonly used lysoso-
mal inhibitors we tried, ammonium chloride (Fig. 6, lane 5;
NH
 
4
 
Cl) had no effect, but chloroquine (Fig. 6, lane 6; Chl)
blocked E-cadherin degradation almost as effectively as the
proteosome inhibitors. In both the PS341- and chloroquine-
treated cells, cytoplasmic pools of E-cadherin increased, but
the increased levels were not reflected by increased adhesion
or higher surface cadherin levels. Thus, these inhibitors ap-
pear to block cadherin degradation, but do not affect inter-
nalization. The data suggest that when newly synthesized
E-cadherin arrives at the cell surface, p120 is required to
prevent the immediate targeting of unbound E-cadherin for
degradation by the proteosome and/or lysosome. We con-
clude that p120 regulates cadherin turnover by controlling
either internalization, or possibly an immediately subse-
quent decision whereby internalized cadherins are sorted
into recycling or degradation pathways.
 
Discussion
 
Here, we provide evidence that the core function of p120 in
cadherin complexes is to regulate cadherin turnover. Pre-
viously, we showed that the stabilizing effect of p120 on
E-cadherin in a p120-deficient SW48 cell line involved a
post-transcriptional mechanism and required direct p120–
E-cadherin interaction (Ireton et al., 2002). However, it was
not clear whether this phenomenon was generally applicable
beyond SW48 cells, nor could we determine the underlying
mechanism. Here, using siRNA and/or p120 reconstitution,
we show that E-cadherin levels depend absolutely on p120
expression. Importantly, this set point mechanism is com-
mon to other (probably all) p120-binding cadherins because
p120 knockdown also induced significant down-regulation
Figure 6. Mechanism of E-cadherin degradation. The effects of 
various inhibitors known to influence cadherin stability were assayed 
in the stable p120 knockdown A431 cells. E-cadherin levels from 
samples treated for 24 h (lanes 1–9) were monitored by Western 
blotting whole-cell lysates and were compared with normal E-cadherin 
levels in the parental cell line (lane 10). Inhibitor concentrations 
were as follows: lactacystin 10  M (lane 1), 3.3  M (lane 2); PS341 
100 nM (lane 3), 33 nM (lane 4), ammonium chloride 5 mM (lane 5), 
Chloroquine 33  M (lane 6), and IETD-CHO 10 nM (lane 7). DMSO 
is the control condition (lane 8). The proteosome inhibitors lactacystin 
and PS341 increased E-cadherin levels (compare lanes 1–4 to lanes 
8 and 9). The lower cadherin levels after 100 nM PS341 (lane 3) 
relative to the 33-nM treatment (lane 4) is due to toxicity at the 
higher concentration. Of the lysosomal inhibitors, chloroquine 
(lane 6), but not ammonium chloride (lane 5), increased E-cadherin 
levels. A caspase 8 inhibitor (lane 7) that has been shown to inhibit 
E-cadherin degradation in myeloma cells had no effect.T
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of P-, VE-, and N-cadherins. The timing and location of
p120 action argue strongly that p120 regulates adhesion via
controlling cadherin turnover at the cell surface. These ob-
servations have crucial implications for roles of p120 in cad-
herin function and cancer.
We believe that the only exception to the requirement for
p120 occurs in cells that express p120 family members such
as ARVCF or 
 
 
 
-catenin. This qualifier is based in part on
cell lines such as HCT116 where the observed reduction in
E-cadherin levels after p120 siRNA expression did not per-
fectly parallel the extent of p120 loss. Indeed, although
ARVCF is typically difficult to detect in many epithelial cell
lines, it is expressed at moderate levels in HCT116 cells (un-
published data). Our data show that ARVCF and 
 
 
 
-catenin
efficiently compensate for p120 loss when ectopically ex-
pressed in A431 cell lines expressing p120 siRNA. Despite
significant structural and sequence similarity, plakophilin-3
had no effect, presumably because it does not bind classical
cadherins. These data strongly imply that surface cadherin
stability is invariably dependent on the binding of either
p120 or a closely related family member, and the presence of
variable levels of p120 family members likely accounts for
the discrepancy in cell lines where p120 knockdown does
not cause a corresponding loss of resident classical cadherins.
The fact that p120 availability limits cadherin levels has sev-
eral crucial implications. For example, overexpression of dom-
inant-negative cadherins frequently down-regulates expression
of endogenous cadherins (Kintner, 1992; Fujimori and Ta-
keichi, 1993; Zhu and Watt, 1996), but the mechanism is un-
known. Our data strongly suggest that a key action of domi-
nant-negative cadherins is the sequestering of endogenous
p120, thereby driving the turnover and degradation of endog-
enous cadherins. In addition, cadherin levels in cells may ulti-
mately be controlled by factors that regulate p120 levels, and
competition for interaction with p120 is likely to be physio-
logically relevant in cells that express more than one cadherin.
In theory, the absence of cadherins in p120-deficient cells
indicates either a failure to normally synthesize cadherins or
an efficient means of eliminating them when p120 is not
present. However, our pulse-chase data indicate that p120 is
not required for normal synthesis or transit of cadherin to the
cell surface. Instead, p120 absence dramatically accelerates
cadherin degradation after its arrival at the surface, indicating
a role in regulating cadherin turnover at the membrane
(modeled in Fig. 7). Our data do not precisely distinguish the
point at which p120 acts to prevent degradation. The sim-
plest explanation is that p120 limits degradation by regulat-
ing internalization. Only cadherin-bound p120 is phosphor-
ylated (Thoreson et al., 2000), and p120 phosphorylation is
the most likely means of regulating p120–cadherin affinity
and/or p120 activity in the complex. We cannot rule out the
less likely possibility that once internalized, p120 might con-
trol the next step, which targets the endocytosed cadherin for
either degradation or recycling back to the surface. Regard-
less, it is likely that the ultimate destruction of the cadherin
in p120-deficient A431 cells resides mainly in the proteo-
some, and to some extent in the lysosome.
Under normal circumstances, cadherin turnover is consti-
tutive and endocytosis is a crucial mechanism for down-reg-
ulating cadherin adhesiveness (Le et al., 1999, 2002; Xiao et
al., 2003). Previously, we postulated that p120 acts as a
switch, inducing the assembly or disassembly of cadherin
complexes through transient signaling events (probably tyro-
sine and serine phosphorylation), which in turn might regu-
late cadherin clustering. Our new data strongly favor a
mechanism whereby dynamic assembly and disassembly of
cadherin complexes is driven primarily by regulation of cad-
herin turnover rather than physical clustering (Fig. 7). A
plausible explanation is that the rate of cadherin turnover is
dictated by events at the cell surface that transiently increase
or decrease p120 affinity for cadherins. The off state favors
internalization/degradation, whereas the on state favors re-
tention/recycling. The low affinity of p120 for cadherins, as
judged by coimmunoprecipitation experiments (Thoreson et
al., 2000), probably reflects the ability of p120 to rapidly al-
ternate between cadherin-bound and -unbound states. It is
worth noting that 
 
 
 
- and 
 
 
 
-catenins are largely passive play-
Figure 7. Model for p120 function in regulating cadherin turnover. 
The low affinity of p120 for cadherins, as judged by coimmunopre-
cipitation experiments, probably reflects the ability of p120 to rapidly 
alternate between cadherin-bound and -unbound states. (1) Our data 
suggest that the rate of cadherin turnover is controlled by cell surface 
events that transiently increase or decrease p120 affinity for cadherins. 
Thus, cadherin complexes exist in a dynamic equilibrium between 
p120-bound and -unbound states, which in turn may be regulated 
by p120 phosphorylation (not depicted). (2) Unbound cadherin is 
targeted for internalization, possibly via a Hakai-like ubiquitination 
mechanism (see Discussion). (3) We cannot yet rule out an alternative 
pathway where p120 binding is irrelevant for internalization, but 
mediates a sorting decision that recycles internalized cadherin back 
to the membrane. (4) Regardless of the exact decision point, unbound 
cadherin is targeted for degradation by the proteosome and/or 
lysosome. Considerable evidence indicates that signaling events at 
the cell surface modulate phosphorylation of the cadherin-bound 
pool of p120. The simplest interpretation of these observations is that 
p120 phosphorylation regulates its steady-state affinity for cadherins, 
which in turn regulates adhesion by controlling the rate of cadherin 
turnover. Note that  - and  -catenin are passive players in this model. 
They likely participate in clustering and certainly mediate the 
cytoskeletal interaction (not depicted), but their role may be secondary 
to regulating surface cadherin levels, which is almost completely 
determined by p120.T
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ers in this model. Because their stability is controlled by cad-
herin binding, their fate is ultimately tied to cadherin levels,
which are clearly controlled by p120. Of course, turnover
and clustering are not mutually exclusive mechanisms, but
our current data suggest that turnover may take precedence.
Recent experiments in 
 
C. elegans
 
 and 
 
Drosophila
 
 indicate
that p120 is not essential in these organisms. Indeed, both
worms (Pettitt et al., 2003) and flies (Myster et al., 2003) are
viable when p120 is removed, and p120-uncoupled E-cad-
herin can substitute effectively for wild-type E-cadherin in
flies (Pacquelet et al., 2003). In contrast, the murine p120
knockout is embryonic lethal (unpublished data). Addition-
ally, our current data show clearly that p120 is essential in
mammalian cells. It is possible that mammalian p120 has
evolved both additional family members and increased com-
plexity to accommodate the developmental demands of
higher organisms.
An unanswered question is the exact targeting mechanism
for internalization and/or degradation of cadherins not asso-
ciated with p120. Because direct binding of p120 to E-cad-
herin is required, it is possible that p120 binding blocks the
interaction of an unknown binding partner (or event) that
targets E-cadherin for degradation. Candidates include pres-
enilin-1 (Baki et al., 2001; Marambaud et al., 2002) and
Hakai (Fujita et al., 2002), which are reported to compete
with p120 for binding the cadherin juxtamembrane domain.
Presenilin-1 binding promotes proteolytic degradation of
E-cadherin (Baki et al., 2001; Marambaud et al., 2002),
whereas Hakai is a ubiquitin ligase that binds tyrosine-phos-
phorylated E-cadherin, leading to its ubiquitination and de-
struction (Fujita et al., 2002). Several tyrosine kinase recep-
tors are turned over via a similar mechanism involving the
oncogene and ubiquitin ligase Cbl, which binds tyrosine-
phosphorylated residues via its classical SH2 domain (for re-
view see Hicke, 1999). However, we were unable to block
E-cadherin destruction in the p120 siRNA cell lines with ei-
ther presenilin or tyrosine kinase inhibitors (unpublished
data). Moreover, the mechanism we describe is common to
several cadherins, whereas the Hakai mechanism appears
specific for E-cadherin. Nonetheless, our data favor a model
where an E-cadherin–targeting event is triggered by the ab-
sence or transient off-loading of p120.
Finally, several lines of evidence suggest that this new role
for p120 in regulating cadherin turnover may be important in
cancer. In cell lines, E-cadherin loss leaves p120 stranded in
the cytoplasm, but has little effect on p120 levels. It is well es-
tablished that E-cadherin loss occurs frequently by mutation
(Berx et al., 1998) and by epigenetic mechanisms (Comijn et
al., 2001; Matsumura et al., 2001) that probably do not in-
volve p120. In contrast, p120 loss clearly represents a different
scenario that directly induces loss of E-cadherin, and thus ulti-
mately, the entire cadherin complex. It follows that p120 loss
may precede cadherin loss in the reported subset of tumors
that have been shown to lack both proteins (for review see
Thoreson and Reynolds, 2002). Accumulating evidence sug-
gests that p120 down-regulation occurs frequently in colon,
prostate, lung, bladder, breast, and several other malignancies
(for review see Thoreson and Reynolds, 2002). p120 is both
mutated and underexpressed in the colon carcinoma cell line
SW48, and indeed, E-cadherin is indeed strongly down-regu-
lated in these cells, providing the first physiologically relevant
example of this phenomena in a carcinoma cell line. However,
no other p120-deficient cell lines have been described, and
physical alterations in the p120 gene locus have not been asso-
ciated with malignancy. Together, these observations suggest
that p120 down-regulation in tumors occurs by an epigenetic
mechanism that has yet to be identified, and raise the possibil-
ity that like E-cadherin, p120 acts as a tumor suppressor.
In conclusion, we show that p120 levels determine
steady-state levels of functional cadherins by regulating
cadherin turnover at the cell surface. This is likely the core
function of p120 in the cadherin complex and suggests that
cadherin adhesiveness is modulated, in part, by signaling
events that dynamically influence p120–cadherin affinity.
In addition, p120 is clearly at the top of the cadherin food
chain in terms of who controls the overall fate of the com-
plex. Together with reports of p120 down-regulation in a
wide range of epithelial tumors, these data suggest a role for
p120 as a tumor suppressor.
 
Materials and methods
 
Cell culture, infections, and transfections
 
HUAECs (CC-2535; Cambrex) were thawed at passage one. They were
grown in endothelial basal medium (CC-3121; Cambrex) supplemented
with EGM SingleQuots
 
®
 
 supplements and growth factors (CC-4133; Cam-
brex). Just before use, HUAEC culture dishes were treated with 0.2% gela-
tin (Sigma-Aldrich, G1393) in PBS for 20 min at 37
 
 
 
C. Culture conditions
for Phoenix cells have been described previously (Ireton et al., 2002), and
all other cell lines were cultured as described elsewhere (Anastasiadis et
al., 2000). For siRNA expression, cells were infected with pRS and se-
lected with 3 to 5 
 
 
 
g/ml puromycin. As indicated, some cells were in-
fected again with LZRS–mp120–neomycin and selected with 600 
 
 
 
g/ml
neomycin. pRS and LZRS retroviruses were produced in the Phoenix cell
packaging line as described previously (Ireton et al., 2002). Clonal A431
cell lines were subcloned by limiting dilution. p120 expression was as-
sessed by immunofluorescence and Western blotting. Transient transfec-
tions were performed with LipofectAMINE™ 2000 (Invitrogen) according
to the manufacturer’s instructions.
 
Immunofluorescence and FACS
 
®
 
Cells were plated sparsely on glass coverslips and incubated for 2 d before
immunofluorescent labeling. Cells were washed once with PBS, then fixed
in 3% PFA for 30 min. Fixed cells were washed with PBS/10 mM glycine
twice and permeabilized in 0.2% Triton X-100/PBS for 5 min. Cells were
again washed in PBS/10 mM glycine and blocked in 3% milk/PBS before
staining. Primary antibodies mAb pp120 (Transduction Laboratories), anti-
 
 
 
-catenin C-2206 (Sigma-Aldrich), anti-
 
 
 
-catenin C-2081 (Sigma-Aldrich),
anti-E-cadherin C-20820 (Transduction Laboratories), and HECD-1 (a gift
from Masatoshi Takeichi, Kyoto University, Kyoto, Japan) were used as de-
scribed previously (Ireton et al., 2002). Other primary antibodies were
used as follows: anti-tubulin (DM1a; Sigma-Aldrich) 1:1000, anti-vinculin
(hvin-1; Sigma-Aldrich) 1:400, anti-myc (mAb 9E10) 1
 
 
 
g/ml, and SHE78–
7 anti E-cadherin (Zymed Laboratories) 1
 
 
 
g/ml. Secondary antibodies goat
anti–mouse IgG1 and IgG2a conjugated either to Alexa
 
®
 
 594 or 488 were
used at 1.7 
 
 
 
g/ml. Cells were mounted in ProLong Antifade (Molecular
Probes, Inc.) according to the manufacturer’s instructions and were visual-
ized on a microscope (Axioplan 2; Carl Zeiss MicroImaging, Inc.) with Im-
mersol 518F oil (Carl Zeiss MicroImaging, Inc.) using a 63
 
 
 
 Plan Apochro-
mat 1.4 aperture objective lens (Carl Zeiss MicroImaging, Inc.). Pictures
were acquired using a camera (Orca-ER; Hamamatsu) and Openlab v3.1.4
software (Improvision).
To isolate pools of cells expressing different levels of E-cadherin, a p120
siRNA-infected A431 cell population was sorted by FACS
 
®
 
 as follows: cells
were dissociated with GIBCO BRL cell dissociation buffer (enzyme free,
PBS based) at 37
 
 
 
C for 45 min. Single-cell suspensions were enhanced by
repeated pipetting, washed in PBS containing 1% serum, and then labeled
with E-cadherin mAb HECD1 (10 
 
 
 
g for 5 
 
 
 
 10
 
6
 
 cells in 1 ml), followed by
washing and then additional labeling with the secondary antibody Alexa
 
®
 
488–conjugated goat anti–mouse IgG (1/1,000 dilution in 1 ml; MolecularT
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Probes, Inc.). After washing, cells were labeled with 7AAD (Molecular
Probes, Inc.) to discriminate dead cells, and subjected to FACS
 
®
 
 using a
FACStar PLUS™ cell sorter (Becton Dickinson). All procedures were per-
formed at 4
 
 
 
C to prevent E-cadherin endocytosis. Four gates were set
based on preliminary experiments designed to separate cells into four cate-
gories of cells expressing high to low levels of E-cadherin. The resulting
pools were expanded and then analyzed by Western blotting for p120 and
E-cadherin levels.
 
Pulse chase, biotinylation, and cell surface trafficking
 
Pulse-chase experiments were performed exactly as described previously
(Ireton et al., 2002). Biotinylation and the rate of cell surface trafficking
were also performed exactly as described previously (Bonifacino et al.,
2003). In brief, cells were plated at 5 
 
 
 
 10
 
5
 
 cells per 60-mm dish for 36 h
before pulse chase. Cells were 
 
35
 
S-labeled for 15 min before chase. At the
end of the chase, cell surface proteins were labeled with 1 mg/ml EZ-Link
sulfo-NHS-SS-biotin (Pierce Chemical Co.) at 4
 
 
 
C for 30 min. E-cadherin
was immunoprecipitated from NP-40 cell lysates, and surface cadherin
was detected by dividing the E-cadherin immunoprecipitations in half,
eluting E-cadherin from the beads with 0.5% SDS, reconstituting elutions
in 50 mM Tris-HCl (pH 7.5), and pulling down biotinylated E-cadherin
with 10 
 
 
 
l per sample of packed streptavidin-coated agarose beads
(Sigma-Aldrich) for 1 h at 4
 
 
 
C. Samples were washed three times with 50
mM Tris-HCl (pH 7.5), and protein was eluted with 2
 
 
 
 Laemmli sample
buffer and analyzed by SDS-PAGE and autoradiography as described pre-
viously (Ireton et al., 2002). Quantification was performed by densitometry
using Image Gage software (Fujifilm Inc.). Arbitrary densitometry units
were plotted with GraphPad Prism (GraphPad Software, Inc.) and adjusted
for background. Biotinylation of total surface cadherin was performed as
described above, but without the pulse-chase labeling.
 
Constructs
 
LZRS–mp120–Neo has been described in detail previously (Ireton et al.,
2002). The pRS vector was a gift from Reuven Agami (The Netherlands
Cancer Institute, Amsterdam, Netherlands). pRS human p120 siRNA and
pRS m siRNA were generated according to Brummelkamp et al. (2002). In
brief, a 64-bp linker was inserted into pRS using the BamHI and HindIII
sites. Oligos for the linker contained p120-specific sense and correspond-
ing antisense sequences, flanking a 6-base hairpin, and were PAGE puri-
fied by Integrated DNA Technologies. pEGFP-C1 
 
 
 
-catenin (Lu et al.,
1999) was a gift from Qun Lu (East Carolina University, Greenville, NC).
pEGFP-C2 ARVCF C11 (Waibler et al., 2001) was a gift from Anna Starzin-
ski-Powitz (Johann Wolfgang Goethe-Universität, Frankfurt, Germany).
pEGFP-C1 (CLONTECH Laboratories, Inc.) was used as a negative control
in transfection experiments.
 
Western blotting
 
Western blotting procedures were conducted as described by Mariner et
al. (2001). In brief, cells were grown to confluence and lysed with either
NP-40 or RIPA buffer. Protein concentrations in lysates were obtained by
copper reduction/bicinchoninic acid (BCA) assay (Pierce Chemical Co.)
according to the manufacturer’s instructions. Primary antibodies were used
as follows: mAb pp120 (0.1 
 
 
 
g/ml), anti-E-cadherin mAbs C-20820
(1/2,500) and HECD-1 (0.1 
 
 
 
g/ml), anti- -catenin pAb C-2206 (1/5,000;
Sigma-Aldrich), and anti- -catenin pAb C-2081 (1/5,000; Sigma-Aldrich).
Secondary antibodies were peroxidase-conjugated donkey anti–mouse
IgG (1/10,000; Jackson ImmunoResearch Laboratories) and mouse anti–
rabbit IgG (1/10,000; Jackson ImmunoResearch Laboratories). Anti-tubulin
(DM1a; Sigma-Aldrich) and anti-vinculin (hvin-1; Sigma-Aldrich) were
used at 1:1,000 and 1:400, respectively.
Inhibitors
Cells were plated at 5   10
5 cells per 60-mm dish for 36 h before treat-
ment with inhibitors. Inhibitors were added to standard growth media at
the following concentrations: 33 nM PS341 (Millenium Pharmaceuticals),
3.3  M lactacystin (Calbiochem), 33  M chloroquine (Sigma-Aldrich), 5
mM ammonium chloride (Sigma-Aldrich), and 10 nM IETD-CHO (Calbio-
chem). Cells were treated with inhibitors for 24 h before lysis in NP-40
buffer and analyzed by Western blotting with E-cadherin mAb HECD-1.
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